Reverse payments

Patent litigation in the pharmaceutical industry is a fierce business. Typically, a brand name drug manufacturer is seeking to stop a competitor from selling a “generic” version of the incumbent’s drug that the incumbent believes infringes its hard won intellectual property.

Download PDF Share Back To Listing
Loading data